Traditional chinese herbal products for coronary heart disease: an overview of cochrane reviews

Yu Qiu, Hao Xu, Dazhuo Shi, Yu Qiu, Hao Xu, Dazhuo Shi

Abstract

Objective. The aim of this overview was to evaluate and summarize Cochrane reviews of traditional Chinese herbal products (TCHPs) as the treatment for coronary heart disease (CHD). Methods. We searched the Cochrane Database that was concerned with the effectiveness of TCHPs for CHD. We also searched the Cochrane Central Register of Controlled Trials. Reviews and primary studies of TCHP as the treatment of any type of CHD were included. Data were extracted according to predefined inclusion criteria by two independent reviewers. Results. Six Cochrane reviews were included. They related to a wide range of TCHPs for different types of CHD. Four reviews were concerned with angina pectoris (unstable or stable), one review was concerned with heart failure, and for acute myocardial infarction. No reviews concluded that TCHPs were definitely effective for CHD because of the weak evidence. Eight primary studies were TCHPs from CHD. These studies also maybe result in bias, but better than before. Conclusion. Several Cochrane reviews of TCHPs for the treatment of different types of CHD have recently been published. None of these reviews got definite conclusion favoring the effectiveness of TCHPs due to the weak evidence. With the improved quality of the new registered RCTs. The potential role of TCHPs in treating CHD is anticipated to be detected.

References

    1. Xu H, Chen K-J. Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chinese Journal of Integrative Medicine. 2011;17(2):83–84.
    1. Lu AP, Ding XR, Chen KJ. Current situation and progress in integrative medicine in China. Chinese Journal of Integrative Medicine. 2008;14(3):234–240.
    1. Chen KJ, Shi DZ, Xu H, et al. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chinese Medical Journal. 2006;119(1):6–13.
    1. Shang QH, Xu H, Lu XY, Wen C, Shi DZ, Chen KJ. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients. Chinese Journal of Integrative Medicine. 2011;17(9):669–674.
    1. Gao Z-Y, Xu H, Shi D-Z, Wen C, Liu B-Y. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine. Journal of Ethnopharmacology. In press.
    1. The Cochrane Collaboration. Cochrane reviews. 2011. .
    1. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5.0.2 [updated September 2009] The Cochrane Collaboration, 2009, .
    1. Wu T, Ni J, Wu J. Danshen (Chinese medicinal herb) preparations for acute myocardial infarction. Cochrane Database of Systematic Reviews. 2008;(2) Article ID CD004465.
    1. Wang Q, Wu T, Chen X, et al. Puerarin injection for unstable angina pectoris. Cochrane Database of Systematic Reviews. 2006;(3) Article ID CD004196.
    1. Zheng H, Chen Y, Chen J, Kwong J, Xiong W. Shengmai (a traditional Chinese herbal medicine) for heart failure. Cochrane Database of Systematic Reviews. 2011;(2) Article ID CD005052.
    1. Duan X, Zhou L, Wu T, et al. Chinese herbal medicine suxiao jiuxin wan for angina pectoris. Cochrane Database of Systematic Reviews. 2008;(1) Article ID CD004473.
    1. Wu T, Harrison RA, Chen X, et al. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database of Systematic Reviews. 2006;(4) Article ID CD004474.
    1. Zhuo Q, Yuan Z, Chen H, Wu T. Traditional Chinese herbal products for stable angina. Cochrane Database of Systematic Reviews. 2010;(5) Article ID CD004468.
    1. Chu FY, Wang J, Sun XW, et al. A randomized double-blinded controlled trial of Xuefu Zhuyu Capsule on short-term quality of life in unstable anginal patients with blood-stasis syndrome after percutaneous coronary intervention. Journal of Chinese Integrative Medicine. 2009;7(8):729–735.
    1. Li YQ, Jin M, Qiu SL, et al. Effect of Chinese drugs for supplementing Qi, nourishing yin and activating blood circulation on myocardial perfusion in patients with acute myocardial infarction after revascularization. Chinese Journal of Integrative Medicine. 2009;15(1):19–25.
    1. Li YQ, Jin M, Qiu SL. Effect of Chinese herbal medicine for benefiting qi and nourishing yin to promote blood circulation on ventricular wall motion of AMI patients after revascularization. Chinese Journal of Integrated Traditional and Western Medicine. 2009;29(4):300–304.
    1. Hu YH, Wu HQ, Qi X. Influence of shenfu injection on heart function and bone marrow stem cell mobilization in patients with chronic heart failure of coronary heart disease. Chinese Journal of Integrated Traditional and Western Medicine. 2009;29(4):309–312.
    1. Tam WY, Chook P, Qiao M, et al. The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients. Journal of Alternative and Complementary Medicine. 2009;15(4):415–421.
    1. Qiu SL, Jin M, Yi JH, Zhu TG, Quan X, Liang Y. Therapy for replenishing qi, nourishing yin and promoting blood circulation in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial. Journal of Chinese Integrative Medicine. 2009;7(7):616–621.
    1. Fan H, Wang XF, Gao W. Effect of Qihong decoction on rehabilitation of patients after coronary artery bypass. Chinese Journal of Integrated Traditional and Western Medicine. 2009;29(3):215–218.
    1. Wang J, He QY, Zhang YL. Effect of Shenshao tablet on the quality of life for coronary heart disease patients with stable angina pectoris. Chinese Journal of Integrative Medicine. 2009;15(5):328–332.
    1. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. Journal of the American Medical Association. 1996;276(8):637–639.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren